[
    [
        {
            "time": "2019-12-23",
            "original_text": "【太平洋医药】第二轮全国集采方案公布，继续推荐景气度好，行业天花板高，不受政策影响/影响较小的细分领域",
            "features": {
                "keywords": [
                    "全国集采",
                    "景气度",
                    "行业天花板",
                    "政策影响",
                    "细分领域"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【太平洋医药】第二轮全国集采方案公布，继续推荐景气度好，行业天花板高，不受政策影响/影响较小的细分领域",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-12-23",
            "original_text": "梳理与展望，盘点2019的“热点”与“冷门” -- 医药行业周报（2019.12.23-2019.12.29）",
            "features": {
                "keywords": [
                    "热点",
                    "冷门",
                    "医药行业",
                    "周报"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "梳理与展望，盘点2019的“热点”与“冷门” -- 医药行业周报（2019.12.23-2019.12.29）",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "2019-12-23",
            "original_text": "【国盛医药张金洋团队】周观点：肝素到底是周期还是成长？——兼论全球肝素产业链重构",
            "features": {
                "keywords": [
                    "肝素",
                    "周期",
                    "成长",
                    "产业链重构"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国盛医药张金洋团队】周观点：肝素到底是周期还是成长？——兼论全球肝素产业链重构",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]